CV DEATH HAS A NEW OPPONENT
CV DEATH HAS A NEW OPPONENT

How Empagliflozin (JARDIANCE) 10 mg provide Cardio-Renal benefits in HFrEF

Document ID: PC-PH-103166

05/07/2022

Author: Boehringer Ingelheim

Related content

 
PC-PH-103166
Production date: December 2022